Genworth Financial Inc.  (GNW) Trade Now »     Rate GNW  -  Discuss GNW  -  Add to Watch List        

Home

Analysis & Videos

Quotes

Bull or Bear

Discuss

GNW: Bull or Bear?

From:    SocialPicks  |  Blogsphere  |  All

SocialPicks Community

New public offering of common stock creates a GAP GNW

N/A

+25.40% in 78 days Genworth. announced that it has priced a public offering of 48.0 million shares of its class A common stock at a public offer price of $11.75 per share. This created a GAP of yesterday's opening price. The market open price of $11.85 is a upward GAP of approx. 5% of previous close. Upward GAP typically happen when supported with strong fundamentals and large institutional buyers are keen to cash on when the prices are still low. Upward GAP will also indicate a strong resistance at 11.85 to any falling price or market adjustments. I recommend BUY on this equity. Continue reading »

Genworth, genuinely dumb... GNW

49%

-128.57% in 25 days (closed on 05/09/09) This may have been a strategic move on Genworth Financial's part but I think I will note that they may be strategic idiots for missing a very big opportunity to become a holding company as a savings and loans institution. This would have given them access to the Federal Reserve free flowing, cheap capital!! What else can we add to the list of things to take away from this strategic company. How about the ability to be eligible for the Treasury's purchase program and now they can't complete the acquisition of Interbank. So I won't pile anything else on this company, because all this news jus... Continue reading »

From the Blogosphere

Notable Analyst Rating Changes 11/2: MOT, GNW, YUM, WY Upgraded; CMCSA, ERJ, RIMM, GERN Downgraded

UPGRADES:Citigroup upgraded Motorola (NYSE: MOT) from Hold to Buy and lifted their price target from $9 to $10.50. Fox-Pitt upgrades Genworth Financial (NYSE: GNW) from In-Line to Outperform. Price target $15. RBC Capital upgrades Yum! Brands (NYSE: YUM) from Sector Perform to Outperform. Credit Suisse upgrades Weyerhaeuser (NYSE: WY) to Neutral. Price target increased to $37. For daily real-time Upgrades go to http://www.streetinsider.com/UpgradesDOWNGRADES:Kaufman Bros. downgrades Comcast (NASDAQ: CMCSA) from Buy to Hold. Price target to $17 from $18. Click Here for more color.Bank of Am... Continue reading »

Notable Analyst Rating Changes 11/02: MOT, UFS, GNW, EL, JWN, WY, RCL, CS Upgraded; RIMM, PALM, CMCSA, ERJ, GERN Downgraded

UPGRADES:Citigroup upgraded Motorola (NYSE: MOT) from Hold to Buy and lifted their price target from $9 to $10.50. JPMorgan, Raymond James and RBC upgrade Domtar (NYSE: UFS) to Overweight, Outperform and Top Pick, respectively.Fox-Pitt upgrades Genworth Financial (NYSE: GNW) from In-Line to Outperform. Price target $15. UBS and Caris upgrade Estee Lauder (NYSE: EL).Deutsche Bank upgrades Nordstrom (NYSE: JWN) to Buy. Price target $45. Click here for the full report.Credit Suisse upgrades Weyerhaeuser (NYSE: WY) to Neutral. Price target increased to $37. Wells Fargo upgrades Royal Caribbean ... Continue reading »

Notable Analyst Rating Change 10/29: FITB, AET, GNW, HGSI, WYN Upgraded; GT, GCI, ATVI, FSLR, KSP Downgraded

UPGRADES:Robert Baird upgraded Fifth Third Bancorp (NASDAQ: FITB) from Neutral to Outperform with an $11 price target. JP Morgan upgrades Aetna (NYSE: AET) from Neutral to Overweight.Bank of America upgrades Genworth Financial (NYSE: GNW) from Neutral to Buy. Price target lowered by $1 to $13. JP Morgan also upgraded Human Genome (NASDAQ: HGSI) to Overweight from Neutral, and raised their price target tp $25 from $14.FBR Research upgrades Wyndham Worldwide (NYSE: WYN) to Outperform. Price target $23. For daily real-time Upgrades go to http://www.streetinsider.com/UpgradesDOWNGRADES:Bank of ... Continue reading »

Analyst upgrades, downgrades and initiations: APC, BWA, CCL, KR, NUE, SNDA, TSO ...

Filed under: Analyst reports, Analyst upgrades and downgrades, Analyst initiations Analyst upgrades: <> Citigroup upgraded Nucor (NYSE: NUE) to Buy from Hold to reflect its positive outlook for steel and expectations the company will return to profitability in Q4. Citi raised its target price on shares to $57 from $46. Oppenheimer upgraded Given Imaging (NASDAQ: GIVN) to Outperform from Perform to reflect solid PillCam Colon data and expected margin improvement. The firm has a $25 target on shares. <>Deutsche Bank upgraded Genworth (NYSE: GNW) to Buy from Hold following the $600M capit... Continue reading »

Notable Analyst Rating Changes 9/17: FWLT, MGM, GNW, VIA, NUE, USB, CSIQ Upgraded; BDK, BWA, BTU, PCX, KR, NTAP Downgraded

UPGRADES:Goldman Sachs upgrades Foster Wheeler AG (Nasdaq: FWLT) from Neutral to Buy with a $41 price target. ARGUS upgrades MGM MIRAGE (NYSE: MGM) two-notches from Sell to Buy. The firm also set an $18 price target.Deutsche Bank upgraded Genworth Financial (NYSE: GNW) from Hold to Buy, saying the $600 million equity capital raise further improves holding company liquidity. The firm raised their price target from $7 to $18. Click here for more color on the upgrade.UBS upgrades Viacom (NYSE: VIA) from Neutral to Buy. Price target $34. Citi upgrades Nucor (NYSE: NUE) from Hold to Buy. Price ... Continue reading »

... more »  

None of the information contained on SocialPicks.com constitutes a recommendation by SocialPicks or its users that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. SocialPicks is not responsible for the posts, discussions, and recommendations of the users on the Site. SocialPicks does not provide investment advice. You must make your own independent decisions regarding any security, portfolio of securities, transaction, or investment strategy mentioned on the website. SocialPicks' users' past results are not necessarily indicative of future performance. Neither SocialPicks nor any of its users guarantees any specific outcome or profit, and you should be aware of the real risk of loss in following any strategy or investments discussed on the website. You understand and agree that you use the Site and Services at your own discretion and risk and that you will be solely responsible for any damages that arise from such use. Before acting on any information contained on the website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.